Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

The Use of Drospirenone/Estetrol in Random Start Rapid Preparation of Endometrium Before Office Hysteroscopic Polypectomies: a Multicenter, Prospective, Randomized Study

ID
Name
DROVPREP
Description
The presence of a thin endometrium plays an important role in enabling the best conditions for hysteroscopic surgery. Recently, for this purpose, many studies have evaluated the effect of preoperative administration of a variety of drugs. We explored the efficacy of random started 14-day administration of drospirenone/estetrol, in rapid preparation of endometrium for hysteroscopic polypectomy.
Trial arms
Trial start
2023-01-01
Estimated PCD
2023-08-01
Trial end
2024-03-01
Status
Completed
Phase
Early phase I
Treatment
drospirenone/estetrol 3mg/14.2mg
Hysteroscopic polipectomy after starting 14-day treatment with oral drospirenone/estetrol 3mg/14.2mg at any time of the menstrual cycle.
Arms:
Intervention
Size
80
Primary endpoint
Quality of endometrial preparation
Intraoperatively
Eligibility criteria
Inclusion Criteria: * Patients with endometrial polyps. Exclusion Criteria: * Patients with other endometrial pathologies.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 80, 'type': 'ACTUAL'}}
Updated at
2024-04-08

1 organization

1 product

2 indications

Organization
University of Palermo
Product
Drospirenone + Estetrol
Indication
Endometrial Polyp
Indication
Endometrial Diseases